Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Karo Bio to present phase III development plan for eprotirome in high-risk HeFH

Aug. 12, 2010

Acrux issues update on female health products

Aug. 11, 2010

Amarin advances phase III AMR-101 trials in patients with high trigliceride levels

Aug. 10, 2010

Repros receives positive feedback on Androxal from FDA

Aug. 10, 2010

Daiichi Sankyo presents new agents for treatment of osteoporosis

Aug. 10, 2010

FDA to complete review of lorcaserin NDA in October

Aug. 9, 2010

Elder Pharmaceuticals discovers new glucose-lowering agents

Aug. 9, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Takeda presents new glucokinase activators

Aug. 6, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...